Health Care • Medical Specialities
$30.19 ▲ +0.67
(+2.27%)
MKT CAP: $1.32B • VOL: 373.2K
52W L $21 52W H $47
TRUP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.44B | $1.29B | $1.11B |
| YoY Revenue Growth % | +11.9% | +16.0% | — |
| Gross Profit | $231.0M | $178.8M | — |
| Gross Margin % | 16.1% | 13.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $13.8M | -$9.5M | -$40.7M |
| Operating Margin % | 1.0% | -0.7% | -3.7% |
| Net Income (GAAP) | $19.4M | -$9.6M | -$44.7M |
| EBITDA (Normalized) | $25.1M | -$1.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $89.5M | $48.3M | $18.6M |
| Capital Expenditures (CapEx) | $14.1M | $9.7M | — |
| Free Cash Flow (FCF) | $75.4M | $38.6M | $18.6M |
| FCF Margin % | 5.2% | 3.0% | 1.7% |
| Return on Invested Capital (ROIC %) | 3.1% | -2.6% | — |
| Cash & Short-Term Equivalents | $138.0M | $160.3M | — |
| Total Debt (Short + Long Term) | $101.8M | $127.5M | — |
| Total Stockholders' Equity | $383.9M | $323.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TRUP.